Effectiveness of a Disease Management Programme for Patients with Type 2 Diabetes Mellitus and Albuminuria in Primary Care - The PROSIT® Project (Proteinuria Screening and Intervention)

Experimental and Clinical Endocrinology and Diabetes

Volumn 112, Issue 2, 2004, Pages 88-94

  Steines, W ^a   Piehlmeier, W ^b   Schenkirsch, G ^b   Renner, R ^a   Landgraf, R ^b  

^a KLINIKUM BOGENHAUSEN   (Germany)

^b LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

Author keywords

Diabetic nephropathy; Disease management; Intervention; Quality management; Type 2 diabetes mellitus

Indexed keywords

ANTIDIABETIC AGENT; ANTIHYPERTENSIVE AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HEMOGLOBIN A1C; INSULIN; METFORMIN; SULFONYLUREA DERIVATIVE;

ADULT; AGED; ARTICLE; CARDIOVASCULAR RISK; CONTROLLED STUDY; DIABETIC NEPHROPATHY; DOCUMENTATION; EUROPE; FEMALE; FOLLOW UP; HEALTH CARE QUALITY; HEALTH PROGRAM; HEART INFARCTION; HIGH RISK POPULATION; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; NON INSULIN DEPENDENT DIABETES MELLITUS; PHYSICIAN; PRACTICE GUIDELINE; PRIMARY HEALTH CARE; PRIORITY JOURNAL; PROTEINURIA; RETROSPECTIVE STUDY; SCREENING TEST;

AGED; ALBUMINURIA; CARDIOVASCULAR DISEASES; DIABETES MELLITUS, TYPE 2; DIABETIC ANGIOPATHIES; FEMALE; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; INCIDENCE; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; RISK FACTORS; SURVIVAL ANALYSIS;

EID: 1842583679     PISSN: 09477349     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2004-815757     Document Type: Article

References (39)

1. Amos AF, McCarty DJ, Zimmet P. The rising global burden of diabetes and its complications: estimates and projections to the year 2010. Diabet Med 1997; 14 (Suppl 5): S1-85
2. Borch-Johnsen K, Wenzel H, Viberti GC, Mogensen CE. Is screening and intervention for microalbuminuria worthwhile in patients with insulin dependent diabetes? (published erratum appears in BMJ 1993; 28: 307: 543) [see comments]. BMJ 306: 1722-1725
3. Borch-Johnsen K, Wenzel H, Viberti GC, Mogensen CE. Is screening and intervention for microalbuminuria worthwhile in patients with insulin dependent diabetes? (published erratum appears in BMJ 1993; 28: 307: 543) [see comments]. BMJ 306: 1722-1725
4. DCCT. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial Research Group [see comments]. N Engl J Med 1993; 329: 977-986
5. Deckert T, Yokoyama H, Mathiesen E, Ronn B, Jensen T, Feldt-Rasmussen B, Borch-Johnsen K, Jensen JS. Cohort study of predictive value of urinary albumin excretion for atherosclerotic vascular disease in patients with insulin dependent diabetes. BMJ 1996; 312: 871-874
6. Detournay B, Fagnani F, Pribil C, Eschwege E. Medical resources consumption of type 2 diabetics in France in 1998. Diabetes Metab 2000; 26: 225-231
7. Gaede P, Vedel P, Parving HH, Pedersen O. Intensified multifactorial intervention in patients with type 2 diabetes mellitus and microalbuminuria: the Steno type 2 randomised study [see comments]. Lancet 1999; 353: 617-622
8. Gaede P, Vedel P, Larsen N, Jensen GVH, Parving HH, Pedersen O. Multifactorial intervention and cardiovascular disease in patients with type 2 diabetes. N Engl J Med 2003; 348: 383-393
9. Garg A: Dyslipoproteinemia and diabetes. Endocrinol Metab Clin North Am 1998; 27: 613-615
10. Grimshaw J, Russel I. Achieving health gain through clinical guidelines: 11: Ensuring guidelines change medical practice. Quality in Health Care 1994; 3: 45-52
11. Hansson L, Zanchetti A, Carruthers SG, Dahlof B, Elmfeldt D, Julius S, Menard J, Rahn KH, Wedel H, Westerling S. Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: principal results of the Hypertension Optimal Treatment (HOT) randomised trial. HOT Study Group [see comments]. Lancet 1998; 351: 1755-1762
12. Hasslacher C. Clinical significance of microalbuminuria and evaluation of the Micral-Test. Clin Biochem 1993; 26: 283-287
13. Jager A, Kostense PJ, Ruhe HG, Heine RJ, Nijpels G, Dekker JM, Bouter LM, Stehouwer CD. Microalbuminuria and peripheral arterial disease are independent predictors of cardiovascular and all-cause mortality, especially among hypertensive subjects: five-year follow-up of the Hoorn Study. Arterioscler Thromb Vasc Biol 1999; 19: 617-624
14. Jonsson B. The economic impact of diabetes. Diabetes Care 1998; 21 (Suppl 3): C7-10
15. Kreisberg RA. Diabetic dyslipidemia. Am J Cardiol 1998; 82: 67 U-73 U
16. Laakso M, Lehto S, Penttila I, Pyorala K. Lipids and lipoproteins predicting coronary heart disease mortality and morbidity in patients with non-insulin-dependent diabetes [see comments]. Circulation 1993; 88: 1421-1430
17. Laakso M. Glycemic control and the risk for coronary heart disease in patients with non-insulin-dependent diabetes mellitus. The Finnish studies. Ann Intern Med 1996; 124: 127-130
18. Lippert J, Ritz E, Schwarzbeck A, Schneider P. The rising tide of end-stage renal failure from diabetic nephropathy type II - an epidemiological analysis [see comments]. Nephrol Dial Transplant 1995; 10: 462-467
19. Luno J, Garcia de Vinuesa S, Gomez-Campdera F, Lorenzo I, Valderrabano F. Effects of antihypertensive therapy on progression of diabetic nephropathy. Kidney Int Suppl 1998; 68: S112-119
20. Mathiesen ER, Ronn B, Storm B, Foght H, Deckert T. The natural course of microalbuminuria in insulin-dependent diabetes: a 10-year prospective study. Diabet Med 1995; 12: 482-487
21. Mogensen CE. Management of early nephropathy in diabetic patients. Ann Rev Med 1995; 46: 79-93
22. Mogensen CE, Viberti GC, Peheim E, Kutter D, Hasslacher C, Hofmann W, Renner R, Bojestig M, Poulsen PL, Scott G, Thoma J, Kuefer J, Nilsson B, Gambke B, Mueller P, Steinbiss J, Willamowski KD. Multicenter evaluation of the Micral-Test II test strip, an immunologic rapid test for the detection of microalbuminuria [see comments]. Diabetes Care 1997; 20: 1642-1646
23. Mogensen CE. Natural history of cardiovascular and renal disease in patients with type 2 diabetes: effect of therapeutic interventions and risk modification. Am J Cardiol 1998; 82: 4 R-8 R
24. Ohkubo Y, Kishikawa H, Araki E, Miyata T, Isami S, Motoyoshi S, Kojima Y, Furuyoshi N, Shichiri M. Intensive insulin therapy prevents the progression of diabetic microvascular complications in Japanese patients with non-insulin-dependent diabetes mellitus: a randomized prospective 6-year study [see comments]. Diabetes Res Clin Pract 1995; 28: 103-117
25. Piehlmeier W, Renner R, Schramm W, Kimmerling T, Garbe S, Proetzsch R, Fahn J, Piwernetz K, Landgraf R. Screening of diabetic patients for microalbuminuria in primary care- The PROSIT-Project. Proteinuria Screening and Intervention. Exp Clin Endocrinol Diabetes 1999; 107: 244-251
26. Piehlmeier W, Renner R, Kimmerling T, Schramm W, Garbe S, Proetzsch R, Fahn J, Piwernetz K, Landgraf R. Evaluation of the Micral-Test S, a Qualitative Immunologic Patient Self-test for Microalbuminuria: the PROSIT Project. Diabetic Medicine 1998; 15: 883-885
27. Poulsen PL, Ebbehoj E, Hansen KW, Mogensen CE. Effects of smoking on 24-h ambulatory blood pressure and autonomic function in normoalbuminuric insulin-dependent diabetes mellitus patients. Am J Hypertens 1998; 11: 1093-1099
28. Ritz E, Lippert J, Keller C. A rapid rise in the number of type-2 diabetics in kidney failure. Not just a problem of nephrologists (editorial). Dtsch Med Wochenschr 1996; 121: 1247
29. Ritz E, Rychl, Locatelli F, Halimi S. End-Stage Renal Failure in Type 2 Diabetes: A Medical Catastrophe of Worldwide Dimensions. Am J Kidney Dis 1999; 34: 795-808
30. Rychlik I, Miltenberger-Miltenyi G, Ritz E. The drama of the continuous increase in end-stage renal failure in patients with type II diabetes mellitus. Nephrol Dial Transplant 1998; 13 (Suppl 8): 6-10
31. SHEP Cooperative Research Group: Prevention of stroke by antihypertensive drug treatment in older persons with isolated systolic hypertension. Final results of the Systolic Hypertension in the Elderly Program (SHEP). SHEP Cooperative Research Group [see comments]. JAMA 1991; 265: 3255-3264
32. Sheth JJ. Diabetes, microalbuminuria and hypertension. Clin Exp Hypertens 1999; 21: 61-68
33. Shichiri M, Kishikawa H, Ohkubo Y, Wake N. Long-term results of the Kumamoto Study on optimal diabetes control in type 2 diabetic patients. Diabetes Care 2000; 23 (Suppl 2): B21-29
34. Tatti P, Pahor M, Byington RP, Di Mauro P, Guarisco R, Strollo G, Strollo F. Outcome results of the Fosinopril Versus Amlodipine Cardiovascular Events Randomized Trial (FACET) in patients with hypertension and NIDDM [see comments]. Diabetes Care 1998; 21: 597-603
35. Thivolet C, Ayzac L, Simonet C, Rebattu B, Bernard P, Tourniaire J. Microalbuminuria and diabetic nephropathy. Detection and correlation with other degenerative complications. Presse Med 1990; 19: 1075-1080
36. UKPDS-Group. Intensive blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38. UK Prospective Diabetes Study Group. BMJ 1998; 317: 703-713
37. UKPDS-Group. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group [see comments]. Lancet 1998 a; 352: 837-853
38. UKPDS-Group. Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). UK Prospective Diabetes Study (UKPDS) Group (published erratum appears in Lancet 1998; 352: 1557) [see comments]. Lancet 1998 b; 352: 854-865
39. UKPDS-Group. Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). UK Prospective Diabetes Study (UKPDS) Group (published erratum appears in Lancet 1998; 352: 1557) [see comments]. Lancet 1998 b; 352: 854-865